Igyxos Company
.jpg)
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Funding Status:
Early Stage Venture
Industry:
Reproductive Health & Contraception
Estimated Revenue:
$1M to $10M
Headquarters:
Nouzilly, Centre, France
Total Funding:
$8,530,579
Last Funding Date:
2019-03-21
Last Funding Type:
Series A
Employee Number:
1-10
Investors Number:
3
Founded Date:
01-01-2017